Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Multiple Versus Single Doses of Exogenous Surfactant for the Prevention or Treatment of Neonatal Respiratory Distress Syndrome: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/. Accessed 03 May 2024.
Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/. Accessed May 3, 2024.
Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/
Multiple Versus Single Doses of Exogenous Surfactant for the Prevention or Treatment of Neonatal Respiratory Distress Syndrome: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome: Cochrane systematic review
ID - 433271
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/
DB - Evidence Central
DP - Unbound Medicine
ER -